Morningside Ventures
About
Morningside was founded in 1986 by the Chan family of Hong Kong to make venture capital and private equity investments. The group is characterized by its long-term outlook in company-building and by its unwavering commitment to acting ethically. As pharmaceutical companies invest in expensive therapies often for diseases of very low incidence, Morningside does not shy away from developing affordable therapies for high-prevalence diseases such as tuberculosis, hepatitis B, asthma, autism and dementia. Long before COVID-19, Morningside has been investing in vaccines, the one medical intervention that has saved more lives in human history than any therapeutic has.
Comments
No comments yet. Be the first to share your take.
Frequently asked
What type of investor is Morningside Ventures?
Morningside was founded in 1986 by the Chan family of Hong Kong to make venture capital and private equity investments. The group is characterized by its long-term outlook in company-building and by its unwavering commitment to acting ethically. As pharmaceutical companies invest in expensive therapies often for diseases of very low incidence, Morningside does not shy away from developing affordab…
What kind of firm is Morningside Ventures?
Morningside Ventures is a Venture Capital.
Where is Morningside Ventures based?
Morningside Ventures is based in China.
What sectors does Morningside Ventures focus on?
Morningside Ventures focuses on Healthcare, Drug Discovery, Life Sciences, Generative AI.